Tsuji, Takao <br/><br/>
A systemically administered EP2 receptor agonist stimulates pulmonary angiogenesis in a murine model of emphysema.  [electronic resource] 

 -  Prostaglandins & other lipid mediators  Dec 2009 
 - 85-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-8823 
<br/><br/><label>Standard No.: </label>10.1016/j.prostaglandins.2009.09.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Dinoprostone--analogs & derivatives<br/>Disease Models, Animal<br/>Lung--blood supply<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Microscopy, Electron, Transmission<br/>Neovascularization, Physiologic--drug effects<br/>Pulmonary Emphysema--drug therapy<br/>Receptors, Prostaglandin E--agonists<br/>Receptors, Prostaglandin E, EP2 Subtype<br/>Vascular Endothelial Growth Factor A--blood